Laura P M H de Rooij (Laura de Rooij)

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 9

Top Topics

Allogeneic Hematopoietic Stem Cell Transplantation

Top Venues

Blood cancer discovery

Communications biology

This page only lists publications with an associated author ORCID identifier.

Publications

Sarah Dobner, Fanni Tóth, Laura P M H de Rooij
A high-resolution view of the heterogeneous aging endothelium. Angiogenesis 27 (2) (2024)
Sarah Dobner, Fanni Tóth, Laura P M H de Rooij
A high-resolution view of the heterogeneous aging endothelium. Angiogenesis (2024)
Sarah Dobner, Fanni Tóth, Laura P M H de Rooij
A high-resolution view of the heterogeneous aging endothelium. Angiogenesis 27 (2) (2024)
Sarah Dobner, Fanni Tóth, Laura P M H de Rooij
A high-resolution view of the heterogeneous aging endothelium. Angiogenesis 27 (2) (2024)
Sarah Dobner, Fanni Tóth, Laura P M H de Rooij
A high-resolution view of the heterogeneous aging endothelium. Angiogenesis 27 (2) (2024)
Sarah Dobner, Fanni Tóth, Laura P M H de Rooij
A high-resolution view of the heterogeneous aging endothelium. Angiogenesis 27 (2) (2024)
Ana Vujovic, Laura P M H de Rooij, Ava Keyvani Chahi, He Tian Tony Chen, Brian A Yee, Sampath Kumar Loganathan, Lina Liu, Derek C H Chan, Amanda Tajik, Emily Tsao, Steven Moreira, Pratik Joshi, Joshua Xu, Nicholas Wong, Zaldy Balde, Soheil Jahangiri, Sasan Zandi, Stefan Aigner, John E Dick, Mark D Minden, Daniel Schramek, Gene W Yeo, Kristin J Hope
In vivo screening unveils pervasive RNA-binding protein dependencies in leukemic stem cells and identifies ELAVL1 as a therapeutic target. Blood cancer discovery (2023)
Liliana Sokol, Anne Cuypers, Anh-Co K Truong, Ann Bouché, Katleen Brepoels, Joris Souffreau, Katerina Rohlenova, Stefan Vinckier, Luc Schoonjans, Guy Eelen, Mieke Dewerchin, Laura P M H de Rooij, Peter Carmeliet
Prioritization and functional validation of target genes from single-cell transcriptomics studies. Communications biology 6 (1) (2023)
Ana Vujovic, Laura P M H de Rooij, Ava Keyvani Chahi, He Tian Tony Chen, Brian A Yee, Sampath Kumar Loganathan, Lina Liu, Derek C H Chan, Amanda Tajik, Emily Tsao, Steven Moreira, Pratik Joshi, Joshua Xu, Nicholas Wong, Zaldy Balde, Soheil Jahangiri, Sasan Zandi, Stefan Aigner, John E Dick, Mark D Minden, Daniel Schramek, Gene W Yeo, Kristin J Hope
In vivo screening unveils pervasive RNA-binding protein dependencies in leukemic stem cells and identifies ELAVL1 as a therapeutic target. Blood cancer discovery (2023)